HuGE Literature Finder
Records 1-30
|
Expression and significance of ETFDH in hepatocellular carcinoma.
Pathology, research and practice 2019 Oct 152702. Wu Yaxun, Zhang Xingsong, Shen Rong, Huang Jieyu, Lu Xiaoyun, Zheng Guihua, Chen Xudo |
|
Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients with Non-alcoholic Fatty Liver Disease.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2019 Aug . Grimaudo Stefania, Pipitone Rosaria Maria, Pennisi Grazia, Celsa Ciro, Cammà Calogero, Di Marco Vito, Barcellona Maria Rosa, Boemi Roberta, Enea Marco, Giannetti Aurora, Spatola Federica, Marchesini Giulio, Craxì Antonio, Petta Salvato |
|
Genomic Sequencing Identifies WNK2 as a Driver in hepatocellular carcinoma and a Risk Factor for Early Recurrence.
Journal of hepatology 2019 Jul . Zhou Shao-Lai, Zhou Zheng-Jun, Hu Zhi-Qiang, Song Cheng-Li, Luo Yi-Jie, Luo Chu-Bin, Xin Hao-Yang, Yang Xin-Rong, Shi Ying-Hong, Wang Zheng, Huang Xiao-Wu, Cao Ya, Fan Jia, Zhou Ji |
|
Androgen Receptor Enhances Hepatic TERT Transcription after Hepatitis B Virus Integration or Point Mutation in Promoter Region.
Hepatology (Baltimore, Md.) 2018 Aug . Li Chiao-Ling, Li Chen-Yu, Lin You-Yu, Ho Ming-Chih, Chen Ding-Shinn, Yeh Shiou-Hwei, Chen Pei-J |
|
Telomerase reverse transcriptase mutations in plasma DNA in patients with hepatocellular carcinoma or cirrhosis: Prevalence and risk factors.
Hepatology communications 2018 Jun 2 (6): 718-731. Jiao Jingjing, Watt Gordon P, Stevenson Heather L, Calderone Tiffany L, Fisher-Hoch Susan P, Ye Yuanqing, Wu Xifeng, Vierling John M, Beretta Lau |
|
Distinction of Intrahepatic Metastasis from Multicentric Carcinogenesis in Multifocal Hepatocellular Carcinoma Using Molecular Alterations.
Human pathology 2017 Nov . Chianchiano Peter, Pezhouh Maryam Kherad, Kim Amy, Luchini Claudio, Cameron Andrew, Weiss Matthew J, He Jin, Voltaggio Lysandra, Oshima Kiyoko, Anders Robert A, Wood Laura |
|
Prevalence of Aflatoxin-associated TP53R249S mutation in Hepatocellular Carcinoma in Hispanics in South Texas.
Cancer prevention research (Philadelphia, Pa.) 2017 Oct . Jiao Jingjing, Niu Weibo, Wang Ying, Baggerly Keith A, Ye Yuanqing, Wu Xifeng, Davenport Dewitt, Almeda Jose Luis, Betancourt-Garcia Monica M, Forse R Armour, Stevenson Heather L, Watt Gordon P, McCormick Joseph B, Fisher-Hoch Susan P, Beretta Lau |
Genome-wide association analysis identifies a GLUL haplotype for familial hepatitis B virus-related hepatocellular carcinoma.
Cancer 2017 Jun . Lin You-Yu, Yu Ming-Whei, Lin Shi-Ming, Lee Shou-Dong, Chen Chih-Ling, Chen Ding-Shinn, Chen Pei-J |
|
The TERT promoter mutation incidence is modified by germline TERT rs2736098 and rs2736100 polymorphisms in hepatocellular carcinoma.
Oncotarget 2017 Apr 8 (14): 23120-23129. Yuan Xiaotian, Cheng Guanghui, Yu Jingya, Zheng Shunzhen, Sun Chao, Sun Qing, Li Kailin, Lin Zhaomin, Liu Tiantian, Li Ping, Xu Yiteng, Kong Feng, Bjorkholm Magnus, Xu Daw |
|
Genetic Features of Aflatoxin-associated Hepatocellular Carcinomas.
Gastroenterology 2017 Mar . Zhang Weilong, He Huan, Zang Mengya, Wu Qifeng, Zhao Hong, Lu Ling-Ling, Ma Peiqing, Zheng Hongwei, Wang Nengjin, Zhang Ying, He Siyuan, Chen Xiaoyan, Wu Zhiyuan, Wang Xiaoyue, Cai Jianqiang, Liu Zhihua, Sun Zongtang, Zeng Yi-Xin, Qu Chunfeng, Jiao Yuch |
|
Genetic Polymorphisms of Fas/FasL Promoter Associated with Hepatitis C cirrhosis and HCC
Asian Pacific journal of cancer prevention : APJCP 2017 10 18 (10): 2683-2688. Abed Sally, El-Dosoky Mohamed, El Sayed Zaki Maysaa, EL-Shafey Moham |
|
Sporadic PCDH18 somatic mutations in EpCAM-positive hepatocellular carcinoma.
Cancer cell international 2017 17 94. Hayashi Takehiro, Yamashita Taro, Okada Hikari, Nio Kouki, Hara Yasumasa, Nomura Yoshimoto, Hayashi Tomoyuki, Asahina Yoshiro, Yoshida Mariko, Oishi Naoki, Sunagozaka Hajime, Takatori Hajime, Honda Masao, Kaneko Shuic |
|
TERT promoter mutations and chromosome 8p loss are characteristic of nonalcoholic fatty liver disease-related hepatocellular carcinoma.
International journal of cancer 2016 Aug . Ki Kim Soo, Ueda Yoshihide, Hatano Etsuro, Kakiuchi Nobuyuki, Takeda Haruhiko, Goto Tomoyuki, Shimizu Takahiro, Yoshida Kenichi, Ikura Yoshihiro, Shiraishi Yuichi, Chiba Kenichi, Tanaka Hiroko, Miyano Satoru, Uemoto Shinji, Chiba Tsutomu, Ogawa Seishi, Marusawa Hiroyu |
|
Tumor specific mutations in TERT promoter and CTNNB1 gene in hepatitis B and hepatitis C related hepatocellular carcinoma.
Oncotarget 2016 Jun . Pezzuto Francesca, Izzo Francesco, Buonaguro Luigi, Annunziata Clorinda, Tatangelo Fabiana, Botti Gerardo, Buonaguro Franco M, Tornesello Maria Li |
|
Genotype-phenotype correlation of CTNNB1 mutations reveals different ß-catenin activity associated with liver tumor progression.
Hepatology (Baltimore, Md.) 2016 May . Rebouissou Sandra, Franconi Andrea, Calderaro Julien, Letouzé Eric, Imbeaud Sandrine, Pilati Camilla, Nault Jean-Charles, Couchy Gabrielle, Laurent Alexis, Balabaud Charles, Bioulac-Sage Paulette, Zucman-Rossi Jessi |
|
The rs3957357C>T SNP in GSTA1 Is Associated with a Higher Risk of Occurrence of Hepatocellular Carcinoma in European Individuals.
PloS one 2016 11 (12): e0167543. Akhdar Hanane, El Shamieh Said, Musso Orlando, Désert Romain, Joumaa Wissam, Guyader Dominique, Aninat Caroline, Corlu Anne, Morel Fabri |
|
Inferring the progression of multifocal liver cancer from spatial and temporal genomic heterogeneity.
Oncotarget 2015 Dec . Shi Jie-Yi, Xing Qingfeng, Duan Meng, Wang Zhi-Chao, Yang Liu-Xiao, Zhao Ying-Jun, Wang Xiao-Ying, Liu Yun, Deng Minghua, Ding Zhen-Bin, Ke Ai-Wu, Zhou Jian, Fan Jia, Cao Ya, Wang Jiping, Xi Ruibin, Gao Qia |
|
Impact of epidermal growth factor receptor protein and gene alteration on Taiwanese hepatocellular carcinomas.
Journal of gastroenterology and hepatology 2015 Sep 30 (9): 1397-404. Su Yu-Hung, Ng Kwai-Fong, Yu Ming-Chin, Wu Ting-Jung, Yeh Ta-Sen, Lee Wei-Chen, Lin Yong-Shiang, Hsieh Tsung-Han, Lin Chun-Yen, Yeh Chau-Ting, Chen Tse-Chi |
|
?-catenin alteration is rare in hepatocellular carcinoma with steatohepatitic features: immunohistochemical and mutational study.
Virchows Archiv : an international journal of pathology 2015 Aug . Ando Sumiyo, Shibahara Junji, Hayashi Akimasa, Fukayama Masas |
|
Multiple genes identified as targets for 20q13.12-13.33 gain contributing to unfavorable clinical outcomes in patients with hepatocellular carcinoma.
Hepatology international 2015 Jul 9 (3): 438-46. Wang Dong, Zhu Zhong-Zheng, Jiang Hongmei, Zhu Jiayi, Cong Wen-Ming, Wen Bing-Ji, He Song-Qin, Liu Shu-Fa |
|
Whole-genome mutational landscape of liver cancers displaying biliary phenotype reveals hepatitis impact and molecular diversity.
Nature communications 2015 6 6120. Fujimoto Akihiro, Furuta Mayuko, Shiraishi Yuichi, Gotoh Kunihito, Kawakami Yoshiiku, Arihiro Koji, Nakamura Toru, Ueno Masaki, Ariizumi Shun-ichi, Nguyen Ha Hai, Shigemizu Daichi, Abe Tetsuo, Boroevich Keith A, Nakano Kaoru, Sasaki Aya, Kitada Rina, Maejima Kazihiro, Yamamoto Yujiro, Tanaka Hiroko, Shibuya Tetsuo, Shibata Tatsuhiro, Ojima Hidenori, Shimada Kazuaki, Hayami Shinya, Shigekawa Yoshinobu, Aikata Hiroshi, Ohdan Hideki, Marubashi Shigeru, Yamada Terumasa, Kubo Michiaki, Hirano Satoshi, Ishikawa Osamu, Yamamoto Masakazu, Yamaue Hiroki, Chayama Kazuaki, Miyano Satoru, Tsunoda Tatsuhiko, Nakagawa Hidewa |
|
Mutation analysis of key genes in RAS/RAF and PI3K/PTEN pathways in Chinese patients with hepatocellular carcinoma.
Oncology letters 2014 Sep 8 (3): 1249-1254. Hou Wenmin, Liu Jibin, Chen Peizhan, Wang Hui, Ye Bang-Ce, Qiang Ful |
|
Identification of driver genes in hepatocellular carcinoma by exome sequencing.
Hepatology (Baltimore, Md.) 2013 Nov 58 (5): 1693-702. Cleary Sean P, Jeck William R, Zhao Xiaobei, Chen Kui, Selitsky Sara R, Savich Gleb L, Tan Ting-Xu, Wu Michael C, Getz Gad, Lawrence Michael S, Parker Joel S, Li Jinyu, Powers Scott, Kim Hyeja, Fischer Sandra, Guindi Maha, Ghanekar Anand, Chiang Derek |
|
Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections.
Genomics 2013 Aug 102 (2): 74-83. Tornesello Maria Lina, Buonaguro Luigi, Tatangelo Fabiana, Botti Gerardo, Izzo Francesco, Buonaguro Franco |
|
Prognostic impact of telomere maintenance gene polymorphisms in hepatocellular carcinoma patients with chronic Hepatitis B.
Hepatology (Baltimore, Md.) 2013 Aug . Jung SW, Park NH, Shin JW, Park BR, Kim CJ, Lee JE, Shin ES, Kim JA, Chung YH |
|
Correlation of TP53 mutations with HCV positivity in hepatocarcinogenesis: identification of a novel TP53 microindel in hepatocellular carcinoma with HCV infection.
Oncology reports 2013 Jul 30 (1): 119-24. Long Jiang, Wang Yan, Li Man, Tong Wei-Min, Jia Ji-Dong, Huang Ji |
|
Analysis of genetic damage and gene polymorphism in hepatocellular carcinoma (HCC) patients in a South Indian population.
Digestive diseases and sciences 2013 Mar 58 (3): 759-67. Mohana Devi Subramaniam, Balachandar Vellingiri, Arun Meyyazhagan, Suresh Kumar Shanmugam, Balamurali Krishnan Balasubramanian, Sasikala Keshavar |
|
S100P expression is a novel prognostic factor in hepatocellular carcinoma and predicts survival in patients with high tumor stage or early recurrent tumors.
PloS one 2013 8 (6): e65501. Yuan Ray-Hwang, Chang Ko-Tung, Chen Yu-Ling, Hsu Hey-Chi, Lee Po-Huang, Lai Po-Lin, Jeng Yung-Mi |
|
A rare point mutation in the Ras oncogene in hepatocellular carcinoma.
Surgery today 2012 Dec . Taketomi A, Shirabe K, Muto J, Yoshiya S, Motomura T, Mano Y, Ikegami T, Yoshizumi T, Sugio K, Maehara Y |
|
Osteopontin promoter polymorphisms at locus -443 significantly affect the metastasis and prognosis of human hepatocellular carcinoma.
Hepatology (Baltimore, Md.) 2012 Oct . Dong QZ, Zhang XF, Zhao Y, Jia HL, Zhou HJ, Dai C, Sun HJ, Qin Y, Ren N, Ye QH, Qin LX |
- Page last reviewed:Oct 1, 2020
- Page last updated:Nov 24, 2020
- Content source: